Funded Startups in Caesarea
Across the 15 most recent funding entries tied to Caesarea (round dates spanning 2021-02-01 to 2026-06-17), the only disclosed round above $20M is NeuReali…
Across the 15 most recent funding entries tied to Caesarea (round dates spanning 2021-02-01 to 2026-06-17), the only disclosed round above $20M is NeuReality’s $20M on 2024-03-19; the next-largest disclosed amount is ConTIPI Medical’s $40M on 2023-06-06, making ConTIPI the clear disclosed-size outlier versus the rest of the disclosed amounts. Several entries cluster tightly in mid-2023: on 2023-06-06, ConTIPI Medical raised $40M and TeraCyte Analytics is listed with an undisclosed amount, and on 2023-10-06 (Gigablue) and 2023-10-01 (Xfloat) there are multiple rounds within a one-week window.
Sector and disclosure mix also skew toward early-stage ambiguity: 10 of 15 rows carry either “Series Unknown” or an unspecified series label (e.g., IceCure Medical $6M on 2026-06-17; CannaSoul Analytics is undisclosed on 2025-11-03), and 4 of 15 rows show “undisclosed” amounts (CannaSoul Analytics 2025-11-03; Gigablue and Xfloat in October 2023; Squalus Medical on 2022-06-15). Biotech appears repeatedly (IceCure Medical 2026-06-17; TeraCyte Analytics 2023-06-06; CardiacSense 2021-02-01), while the most recent disclosed funding event is IceCure Medical’s $6M on 2026-06-17 and the earliest disclosed amount is CardiacSense’s $2M on 2021-02-01.
Most recent rounds
15 shownRelated listings
Frequently asked
What is the largest disclosed funding amount in the Caesarea entries shown, and how does it compare to the rest?
ConTIPI Medical’s $40M on 2023-06-06 is the largest disclosed amount in the 15-row set; the next-largest disclosed figure is NeuReality’s $20M on 2024-03-19, with most other disclosed rounds at $9M or below (e.g., infiniDome $9M on 2023-04-24; Filterlex Medical $8M on 2021-12-21).
Do the round dates cluster into specific windows rather than spreading evenly?
Yes. Mid-2023 is concentrated around 2023-06-06 (ConTIPI Medical $40M plus TeraCyte Analytics with undisclosed funding that date), and there is a separate October 2023 cluster with Gigablue on 2023-10-06 and Xfloat on 2023-10-01 (both with undisclosed amounts).
How much of the list has missing series classifications or undisclosed amounts?
Series information is frequently absent: 10 of 15 rows are labeled “Series Unknown” or have a blank series field (e.g., IceCure Medical $6M on 2026-06-17; NeuReality $20M on 2024-03-19 has a blank series). Amounts are undisclosed in 4 of 15 rows (CannaSoul Analytics 2025-11-03; Gigablue 2023-10-06; Xfloat 2023-10-01; Squalus Medical 2022-06-15).
Which stages show up in the smaller disclosed subset, and are they concentrated or varied?
When series is specified, stages span Seed (Biotic Circular Technologies $2M on 2022-11-08; NeuReality $8M on 2021-02-10), Series A (infiniDome $9M on 2023-04-24; NeuReality appears again with a blank series on 2024-03-19; CardiacSense $2M on 2021-02-01), and a Corporate Round (Squalus Medical is listed as Corporate Round on 2022-06-15 but with an undisclosed amount). The specified-stages are present but the majority of rows remain “Series Unknown”/blank or undisclosed on amount.
Are there identifiable sector clusters (e.g., biotech) that repeat across multiple companies?
Biotech is the clearest repeat: IceCure Medical (Biotechnology) on 2026-06-17 with $6M, TeraCyte Analytics (Biotechnology Research) on 2023-06-06 with an undisclosed amount, and CardiacSense (Biotechnology) on 2021-02-01 with $2M. Other sectors appear fewer times in this slice (e.g., Health Care appears at least twice: Microbot Medical $630K on 2025-08-05 and Squalus Medical on 2022-06-15).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.